Saturday, July 11, 2026

pharma · Phelan-McDermid Syndrome

Jiangnan University

Jiangnan University drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

CN HQ
1902 Founded
1,230 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1902
Employees
1,230
Programs
1
Drugs
1
Patents
0
Intelligence · Drug Pipeline

Jiangnan University pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Jiangnan University drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Jiangnan University in public FDA and regional records.